Research found no significant increase in the incidence of new thyroid cancer cases among patients treated with RAIT for ...

Christine Gustafson shares her story of living with Thyroid Eye Disease, where access to care and understanding often discriminates.

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved teprotumumab (Tepezza), the first medicine licensed ...

Individuals with autoimmune diseases affecting the thyroid can suffer eye complications in the form of Graves’ orbitopathy, in which inflammation in and around the orbit leads to eyelid retraction, ...

A recent study from Bascom Palmer Eye Institute uncovered potential molecular evidence linking human papillomavirus (HPV) to ...

First patients treated with VYVGART Hytrulo pre-filled syringe for self-injection in US and Germany CIDP global expansion with positive CHMP opinion ...

Viridian Therapeutics, Inc. , a biopharmaceutical company focused on discovering, developing, and commercializing potential best-in-class medicines for serious and rare diseases, today announced that ...

Amgen (AMGN) stock in focus as its antibody drug Tepezza becomes U.K.'s first medicine for adults with moderate to severe ...

As with all products, the MHRA will keep its safety under close review. The Medicines and Healthcare products Regulatory ...

Investing.com -- Viridian Therapeutics, Inc. (NASDAQ: VRDN) reported a narrower-than-expected first quarter loss on Tuesday, but shares fell 4.5% as investors focused on the company’s ongoing clinical ...

Thyroid Eye Disease (TED) is increasingly affecting women over 40, causing bulging eyes and potentially leading to sight loss ...